Neuberger Berman Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-9,083
Closed -$1.52M 1828
2020
Q4
$1.52M Hold
9,083
﹤0.01% 1159
2020
Q3
$1.42M Buy
9,083
+1,416
+18% +$285K ﹤0.01% 1130
2020
Q2
$1.6M Buy
7,667
+2,834
+59% +$584K ﹤0.01% 1053
2020
Q1
$902K Buy
4,833
+2,333
+93% +$549K ﹤0.01% 1120
2019
Q4
$604K Buy
+2,500
New +$482K ﹤0.01% 1256

Other funds holding TECX

Neuberger Berman Group's TECX Position: Q1 2021 in Review

Neuberger Berman Group sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 9,083 shares — an estimated $1.52M sold.

Neuberger Berman Group first reported a position in TECX in Q4 2019 and held it in 5 quarters. The position peaked at $1.6M in Q2 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.

  • Neuberger Berman Group reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
  • Neuberger Berman Group sold 9,083 Tectonic Therapeutic shares in Q1 2021, an estimated $1.52M.
  • Neuberger Berman Group first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 5 quarters.
  • Neuberger Berman Group's Tectonic Therapeutic position peaked at $1.6M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.

Based on Neuberger Berman Group's 13F filing for Q1 2021, filed 13 May 2021.